Hangzhou Coco Healthcare Products Co.,Ltd.

SZSE:301009.SZ

11.3 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Revenue 236.196282.967274.716244.169243.805318.794337.168272.995254.492321.635319.801236.316297.538332.749401.937433.923485.521313.751364.457
Cost of Revenue 185.342225.27232.675193.817198.175265.893287.232237.729223.117282.821295.618190.983230.386248.322305.57335.119308.982230.435258.596
Gross Profit 50.85457.69742.04150.35245.6352.90149.93635.26631.37538.81424.18345.33367.15284.42796.36798.804176.53983.315105.861
Gross Profit Ratio 0.2150.2040.1530.2060.1870.1660.1480.1290.1230.1210.0760.1920.2260.2540.240.2280.3640.2660.29
Reseach & Development Expenses 10.40710.21610.8711.2511.55410.43213.04212.84413.73411.36413.30612.33512.95210.68111.75418.81218.6449.6316.834
General & Administrative Expenses -3.3838.895-14.38822.831-2.1716.379-11.85517.217-1.2756.559-10.1321.92-2.1335.514-27.66629.045-15.1834.968-78.907
Selling & Marketing Expenses 36.12123.10530.70125.50422.36120.90424.65420.75127.59822.17727.63125.77818.82618.4520.51914.87516.3413.70334.948
SG&A 41.89232.00116.31348.33420.18927.28312.79937.96826.32328.73717.50147.69916.69423.964-7.14843.921.15818.671-43.959
Other Expenses -1.7020.086-0.0351.985-2.584-0.145-0.9060.128-0.150.024-0.581-1.2570.073-0.00600-2.627-1.1090
Operating Expenses 5441.64445.59547.82643.04338.70644.01238.76548.09340.40951.44152.1637.4935.70227.94844.67538.56927.59175.696
Operating Income -3.14620.802-8.4425.21711.25312.204-66.16414.203-3.9270.42-36.1832.59130.91747.97757.04942.66697.99357.68227.74
Operating Income Ratio -0.0130.074-0.0310.0210.0460.038-0.1960.052-0.0150.001-0.1130.0110.1040.1440.1420.0980.2020.1840.076
Total Other Income Expenses Net 9.7580.086-0.035-0.169-0.43-0.145-0.9060.128-0.150.024-0.581-1.2570.073-0.0060.0070.013-0.002-1.109-0.118
Income Before Tax 6.61220.888-8.4775.04810.82312.058-67.0714.33-4.0770.444-36.7641.33530.99147.9757.05642.67897.99156.57327.622
Income Before Tax Ratio 0.0280.074-0.0310.0210.0440.038-0.1990.052-0.0160.001-0.1150.0060.1040.1440.1420.0980.2020.180.076
Income Tax Expense 0.7422.684-0.4010.50.7160.8762.0910.559-1.97-0.806-3.52-0.7312.4875.85811.0985.95912.3817.0687.243
Net Income 4.88318.332-7.0185.31710.78911.097-57.914.216-1.4031.957-29.7042.08627.11540.24845.95936.71984.00747.32620.379
Net Income Ratio 0.0210.065-0.0260.0220.0440.035-0.1720.052-0.0060.006-0.0930.0090.0910.1210.1140.0850.1730.1510.056
EPS 0.0180.067-0.0210.020.040.041-0.210.052-0.0050.007-0.11-0.0750.130.20.230.180.410.230
EPS Diluted 0.0180.067-0.0210.020.040.041-0.210.052-0.0050.007-0.11-0.0750.130.20.230.180.410.230
EBITDA 12.37623.999-1.1777.99818.61815.3284.60214.621-0.7954.038-24.126-0.84828.98150.83410.74787.736141.29858.28731.342
EBITDA Ratio 0.0520.085-0.0040.0330.0760.0480.0140.054-0.0030.013-0.075-0.0040.0970.1530.0270.2020.2910.1860.086